KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Other Non Operating Income (2018 - 2025)

Vir Biotechnology's Other Non Operating Income history spans 8 years, with the latest figure at -$335000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 33.79% year-over-year to -$335000.0; the TTM value through Dec 2025 reached -$409000.0, up 81.58%, while the annual FY2025 figure was -$409000.0, 81.58% up from the prior year.
  • Other Non Operating Income for Q4 2025 was -$335000.0 at Vir Biotechnology, down from -$228000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $27.0 million in Q3 2022 and bottomed at -$26.2 million in Q4 2022.
  • The 5-year median for Other Non Operating Income is -$257500.0 (2024), against an average of -$839900.0.
  • The largest YoY upside for Other Non Operating Income was 42128.12% in 2022 against a maximum downside of 374000.0% in 2022.
  • A 5-year view of Other Non Operating Income shows it stood at -$7000.0 in 2021, then tumbled by 374000.0% to -$26.2 million in 2022, then surged by 94.33% to -$1.5 million in 2023, then surged by 65.93% to -$506000.0 in 2024, then soared by 33.79% to -$335000.0 in 2025.
  • Per Business Quant, the three most recent readings for VIR's Other Non Operating Income are -$335000.0 (Q4 2025), -$228000.0 (Q3 2025), and $226000.0 (Q2 2025).